FREE TRIAL REQUEST A DEMO
FREE TRIAL REQUEST A DEMO

Toban Zolman

Toban has over 20 years of leadership experience in the development, deployment and validation of computerized systems for clinical trials. As an early employee at ISI, Toban led product development activities across a host of regulatory publishing softwares. He has consulted at 47 of the top 50 pharma companies and worked directly with over 200 companies in 16 countries on regulatory processes to align to electronic submissions standards. As CEO of Kivo, Toban leverages his many years of experience working with regulators combined with best practices in engineering and process management to bring regulatory software into the 21st century. He believes that through digital transformation, life sciences organizations can accelerate the drug development process.

3 min read

Best Practices for End of Study TMF Transfer

In the context of clinical trials, the end of study transfer is a crucial process that involves the transfer of various study-related documents, data, and materials from the sponsor or contract research organization (CRO) to an appropriate entity or...

Read More

3 min read

CTIS Part III: Adapting Your Organization to CTR/CTIS requirements

With CTIS now mandatory, it is imperative for sponsors planning a clinical trial submission in the EU to take all the necessary steps to maintain CTR compliance. Now is the time to make sure your organization is ready across the following key areas: 1)...

Read More

3 min read

CTIS Part II: Document Management Best Practices for CTR Compliance

As highlighted in our previous blog, sponsors submitting trials in the EU will have to adopt a more integrated and collaborative workflow to meet the new submission requirements of EU CTR/CTIS. That in turn, impacts how data and documents are maintained...

Read More

2 min read

CTIS Blog Series Part I: 3 Ways to Prepare your Organization

One of the primary goals of the new Clinical Trial Regulation (CTR), which went into effect in January 2022 and will become mandatory as of January 31st, 2023, is to streamline the process for multinational trials. A sponsor can now apply for...

Read More

2 min read

Kivo Feature Release Round up

Last week we announced our new eTMF product. While that launch has stole the headlines and attention, the Kivo team has been hard at work over the fast few months rolling out a significant number of new features and enhancements across the product line....

Read More

1 min read

Kivo eTMF Now Available

Kivo is excited to announce the release of Kivo eTMF – an eTMF solution for emerging life science companies built on the Kivo platform. Kivo eTMF provides companies with a simple path to compliance for managing Trial Master Files with investigator sites...

Read More

1 min read

Submit documents faster with Kivo’s ICH authoring packages

Emerging life science organizations often deal with authoring processes that are lengthy and complicated. Documents are difficult to format and maintain, and users often spend the bulk of their time figuring out what content is expected by a health...

Read More

1 min read

Kivo Announces Funding to Accelerate Development

Kivo, Inc., a provider of regulatory software, today announced it has closed a $3 million seed round of funding. Kivo will use the investment to scale engineering and sales to meet the growing demand for Kivo's Regulatory Information Management (RIM)...

Read More

1 min read

Kivo is Here!

Kivo enables regulatory teams to accelerate regulatory approvals through improved collaboration and management.

The transition from Gemstone to Kivo is complete. Reimagined from the ground up to fit how emerging life science groups manage regulatory...

Read More

2 min read

Facet Life Sciences Announces Spinout Of Software Division To Kivo

Facet Life Sciences, a leading provider of regulatory strategy and consulting services, today announced it is spinning out its popular Gemstone Electronic Document Management System to an independent company named Kivo with new leadership and...

Read More